GLEN ALLEN, Va. - Adial Pharmaceuticals, Inc. (NASDAQ:ADIL), a biopharmaceutical company specializing in addiction treatment with a current market capitalization of $5.3 million, announced the ...
The study found that Prequel ® Prenatal Screen with AMPLIFY™ technology enables reliable results as early as eight-weeks’ gestation. Typically, prenatal cell-free DNA (pcfDNA) screening is offered ...
In a sign of its ambition to expand its foothold in genomics and grow its contribution to global genomics diversity, M42 and Uzbekistan’s Ministry of Health have signed a Memorandum of Understanding ( ...
Muscular dystrophy is diagnosed using several tests. These may include ... approved to treat people with all genetic variations of DMD. It delays the disease's progression by targeting an enzyme ...